Activity Release Date: 01/01/2018
Activity Expiration Date: 12/31/2018
1-hour Activity | ACCME
This activity is intended for hospitalists, general internists, and subspecialists in internal medicine.
Upon completion of the educational activity, participants should be able to:
CME Credit provided by AKH Inc., Advancing Knowledge in Healthcare
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points and 0 patient safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
This activity is supported by an educational grant from Portola Pharmaceuticals, Inc.
Criteria for Success
In order to receive credit, participants should watch the entire video. Once you have watched the video, you will continue to the online quiz and evaluation. A passing score of 70% on the quiz is required to receive credit. A certificate will be available in your transcripts upon successful completion of the quiz and evaluation. If you have questions about this CME/CE activity, please contact AKH Inc. at firstname.lastname@example.org. There is no fee for this activity.
ABOUT OUR FACULT
Steven L. Cohn, MD, FACP, SFHM
Director – Medical Consultation Service
Jackson Memorial Hospital
Professor Emeritus, University of Miami Miller School of Medicine
Dr. Cohn is currently Professor Emeritus and Director of the Medical Consultation Service at Jackson Memorial Hospital at the University of Miami Miller School of Medicine. He was previously the Medical Director of the UHealth Preoperative Assessment Center (UPAC) and the Medical Consultation Service at the University of Miami Hospital, having relocated to Miami after 30 years at the State University of New York - Downstate Medical Center in Brooklyn. He was the former Chief of the Division of General Internal Medicine and Associate Medical Director for Performance Improvement at Downstate and the Director of the Preoperative Medical Consultation Clinic and Medical Consultation Service at Kings County Hospital Center. He was responsible for education and supervision of senior medical residents in both in-patient and ambulatory care settings.
After receiving his medical degree from the University of Monterrey, Dr. Cohn completed his residency in internal medicine at SUNY - Downstate Medical Center.He is a fellow of the American College of Physicians (ACP), a senior fellow of the Society for Hospital Medicine (SHM), and a board member of the Society for Perioperative Assessment and Quality Improvement (SPAQI).
His clinical and research interests include perioperative medicine, particularly cardiac risk evaluation and management, venous thromboembolic disease, and anticoagulation. Dr. Cohn is a frequently requested grand rounds speaker and has presented research findings and coordinated educational workshops at numerous national professional meetings (ACP, SGIM, SHM) and seminars. In 2017, he received the SHM Award for Excellence in Teaching.
Dr. Cohn is the author/editor of several books - Perioperative Medicine (Springer, 2011), Perioperative Medicine - Just the Facts (McGraw Hill, 2006), section editor for medical consultation in Comprehensive Hospital Medicine (Elsevier, 2007), and Guest Editor for the Medical Clinics of North America (2003). He wrote the chapter on Preoperative Evaluation for Cecil's Textbook of Medicine, the section on Perioperative Medicine in MKSAP XV, and co-authored multiple topics in UpToDate. He has also written book chapters and articles that have appeared in peer-reviewed journals including the Annals of Internal Medicine, Journal of Hospital Medicine, Journal of General Internal Medicine, Heart, and Anesthesiology. Dr. Cohn has been named in Castle Connolly’s Top Doctors in the New York Metro area annually from 1997-2011 and was also listed in New York Magazine's Best Doctors 2010 and 2011.
Dr. Cohn has disclosed the following relevant financial relationships: Speakers Bureau: Janssen and Portola Pharmaceuticals, Inc.
Steven Deitelzweig, M.D., MMM
Medical Director of Regional Business Development System Chairman, Hospital Medicine
Professor of Medicine – Ochsner Clinical School
New Orleans, LA
Dr. Deitelzweig serves as the System Chairman for Hospital Medicine and Medical Director of Regional Business Development of Ochsner Health System in New Orleans, Louisiana. He collaborates on clinical solutions to over 20 partner hospitals within the Ochsner system. Dr. Deitelzweig earned his medical degree from the State University of New York at Stony Brook School of Medicine and completed his residency in internal medicine through Cornell University and Graduate School of Medicine/North Shore University Hospital in New York. Subsequently, he completed fellowships in vascular medicine and hepatology through the Department of Medicine at the Alton Ochsner Medical Foundation in New Orleans. He holds an Executive Masters in Healthcare Administration from the University of New Orleans and completed his Master of Medical Management at Tulane University, New Orleans. He is an Associate Professor of Medicine of the University of Queensland – Ochsner Clinical School.
An extensive lecturer, Dr Deitelzweig presents regionally, nationally and internationally on topics including heart failure, deep venous thrombosis, pulmonary embolism, acute coronary syndrome, atrial fibrillation, and anticoagulation. He has published over 100 abstracts and 50 peer-reviewed publications and serves on the editorial board for Hospitalist News, ACP Hospitalist and is a reviewer for the Journal of Hospital Medicine, Chest, and Thrombosis and Hemostasis. In addition, he has been a principal investigator or sub-investigator on numerous clinical trials.
In addition to serving on the Dr. Deitelzweig is the current Chairman of the Society of Hospital Medicine’s Key Characteristics Working Group, Vice President of the Gulf States Hospitalist Society, and SHMs representative to the AMAs House of Delegates. In addition, he serves on the American College of Cardiology Accreditation Management Governing Board and Board of Directors of the Anticoagulation Forum.
Dr. Deitelzweig has disclosed the following relevant financial relationships:
Contracted Research & Speakers Bureau: Bristol-Myers Squibb, Janssen, Pfizer Inc., Portola Pharmaceuticals, Inc.
AKH STAFF AND PLANNERS
Margaret V. Clark, MSc, RN, RRT - NPS, CMPP, Medical Writer/Interviewer: has disclosed no relevant financial relationships. Dorothy Caputo, MA, BSN, RN, Director of Accreditation, Planner: has disclosed no relevant financial relationships.
Patricia Brignoni, AKH Sr. Project Manager: has disclosed no relevant financial relationships.
Steve Eckert, AKH President & CEO, Planner: has disclosed no relevant financial relationships.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME expectations; referral to National Faculty Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other faculty for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review. AKH planners and reviewers have no relevant financial relationships to disclose.
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.
Copyright 2018 AKH Inc. No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher.